Consultation by a Utah licensed provider for a recommendation to the state program for:

• • ALS (Lou Gehrig’s disease)
  • Alzheimer’s disease
  • Autism
  • Cachexia
  • Cancer
  • Crohn’s disease or ulcerative colitis
  • HIV/AIDS
  • Epilepsy or a similar condition that causes “debilitating seizures”
  • Multiple sclerosis or persistent and debilitating muscle spasms
  • Nausea (must be persistent)
  • Pain lasting longer than two weeks that is not adequately managed despite treatment attempts
  • PTSD “that is being treated or monitored by a licensed mental health therapist”
  • Any terminal illness where life expectancy is less than six months
  • Any condition resulting in hospice care
  • Any rare condition that effects fewer than 200,000 persons in the United States as defined by Section 526 of the Federal Food, Drug and Cosmetic Act and is not adequately managed despite treatment attempts

**Patients with a qualifying illness between the ages of 18 and 21 must petition the Compassionate Use Board for medical cannabis approval